Ferrari, Serge http://orcid.org/0000-0002-1372-4417
Langdahl, Bente
Article History
Accepted: 28 February 2023
First Online: 6 April 2023
Competing interests
: B.L. has received research grants from Amgen and Novo Nordisk, and is on the advisory board and performs lectures for Amgen, Astellas, AstraZeneca, Eli Lilly, Gedeon-Richter, Gilead and UCB. S.F. has received research support from Agnovos, Alexion, Amgen, and UCB, and is on the scientific advisory board of Agnovos, Alexion, Amgen, Boehringer, Flowbone, Fresenius, Labatec, Myovant, Parexel, Radius and UCB.